Genome-Wide Expression Profiling Reveals Downregulation of OTP and CD44 and Upregulation of RET as Indicators of Poor Prognosis in Lung Carcinoids.

MLA

Swarts, D., et al. “Genome-Wide Expression Profiling Reveals Downregulation of OTP and CD44 and Upregulation of RET as Indicators of Poor Prognosis in Lung Carcinoids.” Neuroendocrinology, vol. 96, July 2012, pp. 13–14. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=80169245&authtype=sso&custid=ns315887.

APA

Swarts, D., Van Neste, L., Henfling, M., Van Suylen, R. J., Volante, M., Ramaekers, F., Van Criekinge, W., Van Engeland, M., & Speel, E. J. (2012). Genome-Wide Expression Profiling Reveals Downregulation of OTP and CD44 and Upregulation of RET as Indicators of Poor Prognosis in Lung Carcinoids. Neuroendocrinology, 96, 13–14.

Chicago

Swarts, D., L. Van Neste, M. Henfling, R. J. Van Suylen, M. Volante, F. Ramaekers, W. Van Criekinge, M. Van Engeland, and E. J. Speel. 2012. “Genome-Wide Expression Profiling Reveals Downregulation of OTP and CD44 and Upregulation of RET as Indicators of Poor Prognosis in Lung Carcinoids.” Neuroendocrinology 96 (July): 13–14. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=80169245&authtype=sso&custid=ns315887.